MDM2 is transcriptionally transactivated by p53 and can negatively auto-regulate p53 by ubiquitination (28, 45), therefore MDM2 is considered an oncogene and its amplification or overexpression can increase tumor cell proliferation by suppressing p53 (46). Here, MDM2 is linked to neoplasm.